Welcome to our dedicated page for Mobia Medical SEC filings (Ticker: MOBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Mobia Medical's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Mobia Medical's regulatory disclosures and financial reporting.
Mobia Medical, Inc. disclosure: Synapse Investment and related entities report beneficial ownership of 1,986,072 shares of Common Stock, equal to 6.0% of the class. The filing states these holders share voting and dispositive power over the reported shares.
The reporting parties list their principal business office as c/o SR One Capital Management, LP, Redwood City, CA, and the report was signed pursuant to a power of attorney.
Osage University Partners funds and William Harrington report beneficial ownership of 3,410,899 shares of Mobia Medical common stock, representing 10.3% of the class based on 33,085,391 shares outstanding after the company’s initial public offering.
The position is held through Osage University Partners III and IV, whose general partners share voting and dispositive power, with Harrington as a manager and member of Mobia Medical’s board. The stake arose from multiple preferred stock and note investments that converted into common stock at IPO, plus additional IPO share purchases, and is subject to a 180‑day lock-up and existing registration rights.